Dengvaxia – Infinite Unknown

– Dengue Vaccine Pulled After It May Be Connected To The Deaths Of 14 Children:

The Philippines stated on Friday that the anti-dengue vaccine Dengvaxia may be connected to three deaths in the country, according to a government-ordered inquiry, and that the drug is not ready for mass immunization.

Sanofi the drug maker revealed in November that Dengvaxia – the world’s first dengue vaccine – might increase the risk of severe disease in people who had never been exposed to the virus. This news aroused an uproar in the Philippines, where more than 800,000 school-age children had been vaccinated with the drug in 2016 alone.

Dengue comes from mosquitoes and is the world’s fastest-growing infectious disease, tormenting up to 100 million people worldwide, causing half a million life-threatening infections and killing about 20,000 people, mostly children, every year, Yahoo News reported.

A nurse shows vials of the dengue vaccine Dengvaxia, developed by French medical giant Sanofi Pasteur, at an elementary school in Manila.

– After hundreds of thousands of Filipino kids are vaccinated, Sanofi admits dengue fever vaccine can cause…dengue fever:

Concerned over the health of close to some 500,000 schoolchildren administered with the vaccine Dengvaxia, Senator Richard J. Gordon has expressed alarm over reports that the manufacturer Sanofi has acknowledged its dengue vaccine poses risks to certain recipients.

In what many described as a major Aha! Moment, Sanofi disclosed Thursday that, “for individuals who have not been previously infected by dengue virus, vaccination should not be recommended.”

The situation poses a big and deep quandary, especially for those responsible in the formulation and execution of this mass dengue vaccination program intended to cover one million children nine years old and up.

Early warning